Kelley P Anderson

Summary

Country: USA

Publications

  1. ncbi Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances
    Kelley P Anderson
    Department of Cardiology, Marshfield Clinic, 1000 North Oak Avenue, Marshfield, WI 54449, USA
    Ann Noninvasive Electrocardiol 8:75-89. 2003
  2. ncbi The changing epidemiology of ventricular arrhythmias
    Kelley P Anderson
    University of Wisconsin Medical School, Department of Cardiology, Marshfield, WI 54449 5777, USA
    Cardiol Clin 26:321-33, v. 2008
  3. ncbi Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial
    Param P Sharma
    Department of Cardiology 2C, Marshfield Clinic, 1000 N Oak Ave, Marshfield, WI 54449, USA
    J Interv Card Electrophysiol 19:157-64. 2007
  4. ncbi Lipid-lowering therapy for prevention of ventricular tachyarrhythmias
    Kelley P Anderson
    J Am Coll Cardiol 42:88-92. 2003
  5. ncbi Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
    Alan Kadish
    Clinical Cardiology Trials Office, Division of Cardiology, Department of Medicine, Northwestern University Medical School, Chicago, USA
    N Engl J Med 350:2151-8. 2004
  6. ncbi Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government
    Kelley P Anderson
    J Interv Card Electrophysiol 14:71-8. 2005
  7. ncbi Risk assessment for defibrillator therapy: Il Trittico
    Kelley P Anderson
    J Am Coll Cardiol 50:1158-60. 2007

Collaborators

Detail Information

Publications7

  1. ncbi Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances
    Kelley P Anderson
    Department of Cardiology, Marshfield Clinic, 1000 North Oak Avenue, Marshfield, WI 54449, USA
    Ann Noninvasive Electrocardiol 8:75-89. 2003
    ..Further research is needed to determine if other approaches to SNSA modulation can enhance the antiarrhythmic effects...
  2. ncbi The changing epidemiology of ventricular arrhythmias
    Kelley P Anderson
    University of Wisconsin Medical School, Department of Cardiology, Marshfield, WI 54449 5777, USA
    Cardiol Clin 26:321-33, v. 2008
    ..Recent evidence for unfavorable trends for SCD and CHD mortality raises the specter of a reversal in the gains made against fatal VTA in recent decades...
  3. ncbi Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial
    Param P Sharma
    Department of Cardiology 2C, Marshfield Clinic, 1000 N Oak Ave, Marshfield, WI 54449, USA
    J Interv Card Electrophysiol 19:157-64. 2007
    ..We compared characteristics and mortality of patients from a community population meeting enrollment criteria of the second Multicenter Automatic Defibrillator Implantation Trial (MADIT II) to those of the MADIT II subjects...
  4. ncbi Lipid-lowering therapy for prevention of ventricular tachyarrhythmias
    Kelley P Anderson
    J Am Coll Cardiol 42:88-92. 2003
  5. ncbi Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
    Alan Kadish
    Clinical Cardiology Trials Office, Division of Cardiology, Department of Medicine, Northwestern University Medical School, Chicago, USA
    N Engl J Med 350:2151-8. 2004
    ..However, the value of prophylactic implantation of an implantable cardioverter-defibrillator (ICD) to prevent sudden death in such patients is unknown...
  6. ncbi Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government
    Kelley P Anderson
    J Interv Card Electrophysiol 14:71-8. 2005
    ....
  7. ncbi Risk assessment for defibrillator therapy: Il Trittico
    Kelley P Anderson
    J Am Coll Cardiol 50:1158-60. 2007